734 related articles for article (PubMed ID: 23355908)
21. Early-Stage Induction of SWI/SNF Mutations during Esophageal Squamous Cell Carcinogenesis.
Nakazato H; Takeshima H; Kishino T; Kubo E; Hattori N; Nakajima T; Yamashita S; Igaki H; Tachimori Y; Kuniyoshi Y; Ushijima T
PLoS One; 2016; 11(1):e0147372. PubMed ID: 26812616
[TBL] [Abstract][Full Text] [Related]
22. Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy.
Shi Y; Shin DS
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371564
[TBL] [Abstract][Full Text] [Related]
23. SWI/SNF: a chromatin-remodelling complex with a role in carcinogenesis.
Halliday GM; Bock VL; Moloney FJ; Lyons JG
Int J Biochem Cell Biol; 2009 Apr; 41(4):725-8. PubMed ID: 18723114
[TBL] [Abstract][Full Text] [Related]
24. The genetic alteration spectrum of the SWI/SNF complex: The oncogenic roles of BRD9 and ACTL6A.
Sima X; He J; Peng J; Xu Y; Zhang F; Deng L
PLoS One; 2019; 14(9):e0222305. PubMed ID: 31504061
[TBL] [Abstract][Full Text] [Related]
25. Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler.
Woodley CM; Romer AS; Wang J; Guarnaccia AD; Elion DL; Maxwell JN; Guerrazzi K; McCann TS; Popay TM; Matlock BK; Flaherty DK; Lorey SL; Liu Q; Tansey WP; Weissmiller AM
Oncogene; 2021 May; 40(20):3593-3609. PubMed ID: 33931740
[TBL] [Abstract][Full Text] [Related]
26. The SWI/SNF complex in cancer - biology, biomarkers and therapy.
Mittal P; Roberts CWM
Nat Rev Clin Oncol; 2020 Jul; 17(7):435-448. PubMed ID: 32303701
[TBL] [Abstract][Full Text] [Related]
27. SWI/SNF complexes and cancers.
Wang L; Tang J
Gene; 2023 Jun; 870():147420. PubMed ID: 37031881
[TBL] [Abstract][Full Text] [Related]
28. BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2.
Hill DA; de la Serna IL; Veal TM; Imbalzano AN
J Cell Biochem; 2004 Apr; 91(5):987-98. PubMed ID: 15034933
[TBL] [Abstract][Full Text] [Related]
29. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.
Wang X; Sansam CG; Thom CS; Metzger D; Evans JA; Nguyen PT; Roberts CW
Cancer Res; 2009 Oct; 69(20):8094-101. PubMed ID: 19789351
[TBL] [Abstract][Full Text] [Related]
30. Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells.
Pfister NT; Fomin V; Regunath K; Zhou JY; Zhou W; Silwal-Pandit L; Freed-Pastor WA; Laptenko O; Neo SP; Bargonetti J; Hoque M; Tian B; Gunaratne J; Engebraaten O; Manley JL; Børresen-Dale AL; Neilsen PM; Prives C
Genes Dev; 2015 Jun; 29(12):1298-315. PubMed ID: 26080815
[TBL] [Abstract][Full Text] [Related]
31. Advances in the role of SWI/SNF complexes in tumours.
Li Z; Zhao J; Tang Y
J Cell Mol Med; 2023 Apr; 27(8):1023-1031. PubMed ID: 36883311
[TBL] [Abstract][Full Text] [Related]
32. The SWI/SNF tumor suppressor complex: Regulation of promoter nucleosomes and beyond.
Lu P; Roberts CW
Nucleus; 2013; 4(5):374-8. PubMed ID: 24145903
[TBL] [Abstract][Full Text] [Related]
33. [Chromatin remodeling defects and cancer: the SWI/SNF example].
Bourdeaut F; Bièche I
Bull Cancer; 2012 Dec; 99(12):1133-40. PubMed ID: 23222069
[TBL] [Abstract][Full Text] [Related]
34. Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathway.
He L; Chen Y; Feng J; Sun W; Li S; Ou M; Tang L
Int J Biochem Cell Biol; 2017 Sep; 90():29-37. PubMed ID: 28716547
[TBL] [Abstract][Full Text] [Related]
35. BAF60a interacts with p53 to recruit the SWI/SNF complex.
Oh J; Sohn DH; Ko M; Chung H; Jeon SH; Seong RH
J Biol Chem; 2008 May; 283(18):11924-34. PubMed ID: 18303029
[TBL] [Abstract][Full Text] [Related]
36. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.
Alpsoy A; Dykhuizen EC
J Biol Chem; 2018 Mar; 293(11):3892-3903. PubMed ID: 29374058
[TBL] [Abstract][Full Text] [Related]
37. SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
Agaimy A; Amin MB; Gill AJ; Popp B; Reis A; Berney DM; Magi-Galluzzi C; Sibony M; Smith SC; Suster S; Trpkov K; Hes O; Hartmann A
Hum Pathol; 2018 Jul; 77():139-146. PubMed ID: 29689242
[TBL] [Abstract][Full Text] [Related]
38. SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases.
Li Y; Yang X; Zhu W; Xu Y; Ma J; He C; Wang F
Cancer Cell Int; 2022 Nov; 22(1):347. PubMed ID: 36371186
[TBL] [Abstract][Full Text] [Related]
39. In silico screening of cancer-associated mutations in the HSA domain of BRG1 and its role in affecting the Arp-HSA sub-complex of SWI/SNF.
S AS; Goutham R N A; Mohan S S
Comput Biol Chem; 2018 Dec; 77():109-115. PubMed ID: 30286321
[TBL] [Abstract][Full Text] [Related]
40. SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.
Middeljans E; Wan X; Jansen PW; Sharma V; Stunnenberg HG; Logie C
PLoS One; 2012; 7(3):e33834. PubMed ID: 22442726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
